Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Organon & Co. Common Stock
(NY:
OGN
)
13.32
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Apr 28, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
94,678
Open
13.32
Bid (Size)
13.27 (3,300)
Ask (Size)
13.31 (700)
Prev. Close
13.32
Today's Range
13.32 - 13.32
52wk Range
5.690 - 13.38
Shares Outstanding
259,965,579
Dividend Yield
0.60%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Organon Cancels First Quarter Earnings Call
Today 7:30 EDT
From
Organon & Co.
Via
Business Wire
Organon & Co. Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Organon & Co. - OGN
April 28, 2026
From
Kahn Swick & Foti, LLC
Via
Business Wire
Performance
YTD
+84.0%
+84.0%
1 Month
+133.7%
+133.7%
3 Month
+48.0%
+48.0%
6 Month
+100.0%
+100.0%
1 Year
+4.7%
+4.7%
More News
Read More
Halper Sadeh LLC is Investigating Whether OGN, XOMA, RMAX, SLNO are Obtaining Fair Deals for their Shareholders
April 27, 2026
From
Halper Sadeh LLC
Via
GlobeNewswire
Stock Market Today, April 27: Organon Shares Surge After Sun Pharma Agrees to Acquire Company in All Cash Deal
↗
April 27, 2026
Via
The Motley Fool
Topics
Stocks
Monday's session: most active stocks
↗
April 27, 2026
Via
Chartmill
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX), Soleno Therapeutics, Inc. (Nasdaq – SLNO)
April 27, 2026
From
Brodsky & Smith LLC
Via
GlobeNewswire
OGN Stock Alert: Halper Sadeh LLC is Investigating Whether Organon & Co. is Obtaining a Fair Price for its Shareholders
April 27, 2026
From
Halper Sadeh LLC
Via
Business Wire
Sun Pharma signs Definitive Agreement to Acquire Organon
April 26, 2026
From
Organon & Co.
Via
Business Wire
There are notable gap-ups and gap-downs in today's session.
↗
April 24, 2026
Via
Chartmill
What's going on in today's pre-market session
↗
April 24, 2026
Via
Chartmill
Organon’s VTAMA® (tapinarof) cream, 1%, Granted Strong Recommendation in the 2026 American Academy of Dermatology Guidelines for Pediatric Atopic Dermatitis
April 15, 2026
From
Organon & Co.
Via
Business Wire
3 Reasons to Avoid OGN and 1 Stock to Buy Instead
April 13, 2026
Via
StockStory
Topics
Stocks
Traders are paying attention to the gapping stocks in Friday's session.
↗
April 10, 2026
Via
Chartmill
Topics
Artificial Intelligence
Discover the top movers in Friday's pre-market session.
↗
April 10, 2026
Via
Chartmill
Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know
April 06, 2026
Via
StockStory
Topics
Government
Stocks
Organon Debuts New Analysis of VTAMA® (tapinarof) cream, 1%, Phase 3 Pooled Data Demonstrating Early and Consistent Skin Clearance and Itch Improvement in Atopic Dermatitis Patients Down to 2 Years of Age
March 27, 2026
From
Organon & Co.
Via
Business Wire
3 Cash-Producing Stocks We’re Skeptical Of
March 23, 2026
Via
StockStory
Topics
Fraud
Does This $25 Million Bet on a Stock Down 61% Signal Turnaround Potential at $6?
↗
March 20, 2026
Via
The Motley Fool
3 Value Stocks We Approach with Caution
March 20, 2026
Via
StockStory
1 Stock Under $10 to Own for Decades and 2 That Underwhelm
March 19, 2026
Via
StockStory
3 of Wall Street’s Favorite Stocks We Approach with Caution
March 13, 2026
Via
StockStory
3 Small-Cap Stocks We Approach with Caution
March 04, 2026
Via
StockStory
New Analysis of Organon’s VTAMA® (tapinarof) cream, 1%, Phase 3 Data Showed Early and Consistent Improvement in Patient-Reported Sleep Subdomains in Pediatric Patients Down to 2 Years of Age with Atopic Dermatitis
February 27, 2026
From
Organon & Co.
Via
Business Wire
The Pivot to Growth: Viatris (VTRS) Enters Phase 2 with 2026 Dividend and Capital Allocation Strategy
February 26, 2026
Via
Finterra
Topics
Economy
Organon Enters into Agreement to License MIUDELLA®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device
February 23, 2026
From
Organon & Co.
Via
Business Wire
Frequently Asked Questions
Is Organon & Co. Common Stock publicly traded?
Yes, Organon & Co. Common Stock is publicly traded.
What exchange does Organon & Co. Common Stock trade on?
Organon & Co. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Organon & Co. Common Stock?
The ticker symbol for Organon & Co. Common Stock is OGN on the New York Stock Exchange
What is the current price of Organon & Co. Common Stock?
The current price of Organon & Co. Common Stock is 13.32
When was Organon & Co. Common Stock last traded?
The last trade of Organon & Co. Common Stock was at 04/28/26 07:00 PM ET
What is the market capitalization of Organon & Co. Common Stock?
The market capitalization of Organon & Co. Common Stock is 3.46B
How many shares of Organon & Co. Common Stock are outstanding?
Organon & Co. Common Stock has 3B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.